Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London

Whitehawk Therapeutics (Nasdaq: WHWK) announced that Dave Lennon, PhD, President and CEO, will present at the Jefferies Global Healthcare Conference in London on November 18, 2025 at 11:30 AM GMT.

Rhea-AI Summary

Whitehawk Therapeutics (Nasdaq: WHWK) announced that Dave Lennon, PhD, President and CEO, will present at the Jefferies Global Healthcare Conference in London on November 18, 2025 at 11:30 AM GMT.

A live webcast of the presentation will be available via the company's investor relations website and will be available for replay for approximately 30 days following the event.

Argus Nov 11 session

+2.29% close to close Open Argus

Details

News Market Reaction – WHWK

On Nov 11, the day this news came out, WHWK closed 2.29% above the previous close.

Data tracked by StockTitan Argus for the Nov 11 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MORRISTOWN, N.J., Nov. 11, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC) cancer treatments, today announced that Dave Lennon, PhD, President and CEO, will present at the Jefferies Global Healthcare Conference in London on November 18, 2025, at 11:30 AM GMT.

A live webcast of the presentation can be accessed by visiting the Whitehawk Therapeutics IR website and will be available for replay for approximately 30 days following the event.

About Whitehawk Therapeutics 
Whitehawk Therapeutics is an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk's advanced three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from WuXi Biologics under an exclusive development and global commercialization agreement. More information on the Company is available at www.whitehawktx.com and connect with us on LinkedIn.

Contact:
IR@whitehawktx.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/whitehawk-therapeutics-to-present-at-jefferies-global-healthcare-conference-in-london-302611063.html

SOURCE Whitehawk Therapeutics, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Whitehawk Therapeutics (WHWK) present at the Jefferies Global Healthcare Conference?

Whitehawk Therapeutics (WHWK) will present on November 18, 2025 at 11:30 AM GMT.

How can investors watch the Whitehawk Therapeutics (WHWK) presentation on November 18, 2025?

Investors can watch a live webcast accessible via Whitehawk Therapeutics' investor relations website.

Will the Whitehawk Therapeutics (WHWK) webcast be available for replay and for how long?

Yes. The webcast will be available for replay for approximately 30 days after the event.

Who from Whitehawk Therapeutics (WHWK) will present at the Jefferies Global Healthcare Conference?

Dave Lennon, PhD, President and CEO of Whitehawk Therapeutics (WHWK), will present.

Where on the web will the Whitehawk Therapeutics (WHWK) presentation be posted?

The presentation webcast will be posted on Whitehawk Therapeutics' investor relations website.

Does the Whitehawk Therapeutics (WHWK) announcement include earnings or guidance details?

No. The announcement only notes the presentation date, time, presenter, and webcast availability; it does not include earnings or guidance.